COVID-19 Prophylaxis is under YOUR Control
With the peak of the COVID-19 crisis behind us, for many of us, we talk to more people, and obviously, a main topic remains the
With the peak of the COVID-19 crisis behind us, for many of us, we talk to more people, and obviously, a main topic remains the
Professor Perronne’s book “Is there a mistake they did not do? COVID-19: the sacred union of incompetence and arrogance” continues to make waves in France,
These are notes relating to a video of a recent TV programme in Brazil about COVID-19 and hydroxychloroquine-based treatments. They were put together by a
“This is your Darkest Hour, Boris: let’s have some real leadership. Without that, God help us all.” While the #OxfordGate #RecoveryGate #CovidPapers story is still
The governmental research institute of the Canadian province of Quebec, the INESSS, published on June 15 an update to its position on chloroquine / hydroxychloroquine.
At a media conference this Tuesday, COVID-19 survivor and UK prime minister Boris Johnson announced “the biggest breakthrough yet” regarding therapies for the coronavirus. THIS
“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result,” said Peter Horby, Professor of Emerging Infectious
Despite therapeutic successes with hydroxychloroquine around the world, and significant usage by many doctors in the US, who regularly report success in using the drug,
This article, published (in English and French) in the leading online French newspaper France Soir, asserts that the UK therapeutic approach to COVID-19 is flawed,
The study “Pre-exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers, by Bhattacharya and collaborators, found efficacy in pre-exposure prophylaxis for medical
The generic antibiotic azithromycin, one of the world’s essential medicines according to the World Health Organization, is now in the crosshairs of French health minister
Little noticed was an announcement on May 27 by the Oxford RECOVERY trial that Remdesivir was now available for those participating in the trial, encompassing